Discoid lupus erythematosus (DLE), which is a cutaneous form of lupus erythematosus (LE), is generally refractory to a wide range of topical or systemic therapies. Although the main treatment option for DLE is topical steroids, it is often ineffective or likely to produce long-term side effects. New drugs, including tacrolimus and pimecrolimus, have been developed to overcome the adverse effects of steroids and treat the lesions of DLE for a prolonged period. We herein report 4 cases of facial DLE successfully treated with therapeutic adjuvants, topical tacrolimus or pimecrolimus.
Four cases of facial discoid lupus erythematosus successfully treated with topical pimecrolimus or tacrolimus.
Ye-Won Han,Hyung Ok Kim,S. Park,Y. Park
Published 2010 in Annals of Dermatology
ABSTRACT
PUBLICATION RECORD
- Publication year
2010
- Venue
Annals of Dermatology
- Publication date
2010-08-01
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-20 of 20 references · Page 1 of 1
CITED BY
Showing 1-11 of 11 citing papers · Page 1 of 1